MIT Uses AI to Make mRNA Vaccines Stable at Room Temperature for a Year

MIT engineers used AI to develop a new mRNA vaccine formulation that stabilizes lipid nanoparticles, allowing vaccines to survive a year at room temperature and two months at about 38°C, potentially eliminating cold-chain requirements and greatly expanding distribution.

2026-10-01 ~ 2026-10-01 · 2 related posts

• MIT uses AI to design thermostable mRNA vaccines that need no cold chain — rohanpaul_ai · 2026-10-01

1 near-duplicate retellings: rohanpaul_ai